Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) clinical trial (NCT07164443). Contact the study team or your healthcare provider for specific answers.

Question 2

How does pasritamig compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) clinical trial (NCT07164443). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of supportive care will I receive during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) clinical trial (NCT07164443). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) clinical trial (NCT07164443). Contact the study team or your healthcare provider for specific answers.

Question 5

What are the possible side effects of pasritamig?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) clinical trial (NCT07164443). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my overall health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) clinical trial (NCT07164443). Contact the study team or your healthcare provider for specific answers.

What this study is about